Natalia Kovtun: Comparing Gastrointestinal Bleeding Rates Between DOAC Monotherapy and Aspirin
Natalia Kovtun, Internist at Baptist Health Deaconess Madisonville and Marion Veterans Affairs Medical Center, shared a post on LinkedIn about a recent article by Pier-Valerio Mari et al., published in Gastrointestinal Disorders, adding:
“Direct oral anticoagulant (DOAC) monotherapy and aspirin users have comparable upper gastrointestinal (GI) bleed rates whereas DOAC users have numerically lower rates of lower GI bleed (LGIB) rates in the emergency department (ED).
These findings, from a retrospective study, were published in Gastrointestinal Disorders.”
Title: Site of Gastrointestinal Bleeding in Patients on Direct Oral Anticoagulants Versus Aspirin Monotherapy: A Single-Centre Retrospective Cohort Study
Authors: Pier-Valerio Mari, Annalisa Schifano, Angela Saviano, Andrea Piccioni, Giacomo Costati, Carmine Petruzziello, Veronica Ojetti
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 10, 2026, 16:28Can the VWF to ADAMTS-13 Ratio Predict Mortality in Sepsis-Induced Coagulopathy? – RPTH Journal
-
Nov 10, 2026, 16:28Ruth Willems: PhD Defence at Maastricht University on Thrombosis and Bleeding in HPB Disease
-
Nov 10, 2026, 16:09Edward Lee Carter: Factor XIa Inhibition Enters Clinical Practice
-
Nov 10, 2026, 16:08Edward C.C. Wong: Deriving Ferritin Cutoffs for Iron Deficiency Using RBC Parameters
-
Nov 10, 2026, 16:07Milad Abdalla: Decoding Hemoglobin Electrophoresis – A Practical Diagnostic Reference
-
Nov 10, 2026, 15:13Wolfgang Miesbach: Nonviral Gene Therapy for Haemophilia A Using Lipid Nanoparticles
-
Nov 10, 2026, 15:06Dahra Teles: First Speaking Experience at HEMO 2026 on First-Line Multiple Myeloma Treatment
-
Nov 10, 2026, 14:55Yazan Abou-Ismail: First FDA-Approved Factor XIa Inhibitor for Stroke Prevention
-
Nov 10, 2026, 14:49Ifeanyichukwu Ifechidere: The Role of Coagulation in Anaesthesia and Surgery